Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of CYP2C19*2 polymorphism on clopidogrel response in young patients with coronary artery disease
2007-004901-91Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clopidogrel in coronary arteriosclerosis and cardiac ischemia (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2007; status: active.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosiscardiac ischemia
Beyond the preview
Go deeper on 2007-004901-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004901-91.